126 related articles for article (PubMed ID: 29069923)
1. Comparison of two assays measuring human chorionic gonadotrophin serum concentrations in pregnancy termination and trophoblastic or non-trophoblastic tumours.
Wolff F; Gervy C; Gulbis B; Cotton F
Scand J Clin Lab Invest; 2017 Dec; 77(8):689-693. PubMed ID: 29069923
[TBL] [Abstract][Full Text] [Related]
2. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human chorionic gonadotrophin concentrations in the sera of patients with normal and abnormal pregnancy measured by radio-immunoassay and immunoradiometric assay.
Norman RJ; Buck RH; Joubert SM
S Afr Med J; 1989 Apr; 75(7):318-9. PubMed ID: 2538933
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
Ozturk M
J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
[TBL] [Abstract][Full Text] [Related]
5. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
Cole LA; Butler S
J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
7. Some qualitative differences of hCG in serum from early and late pregnancies and trophoblastic diseases.
Wide L; Hobson B
Acta Endocrinol (Copenh); 1987 Dec; 116(4):465-72. PubMed ID: 2827418
[TBL] [Abstract][Full Text] [Related]
8. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
Cole LA; Kohorn EI; Kim GS
J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
[TBL] [Abstract][Full Text] [Related]
9. Utility of assay of alpha subunit of human chorionic gonadotropin in management of gestational, trophoblastic malignancies.
Quigley MM; Tyrey L; Hammond CB
Am J Obstet Gynecol; 1980 Nov; 138(5):545-9. PubMed ID: 6158863
[TBL] [Abstract][Full Text] [Related]
10. Human chorionic gonadotropin assays and their uses.
Tyrey L
Obstet Gynecol Clin North Am; 1988 Sep; 15(3):457-75. PubMed ID: 2852329
[TBL] [Abstract][Full Text] [Related]
11. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease.
Cole LA
J Reprod Med; 1998 Jan; 43(1):3-10. PubMed ID: 9475142
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
Zhang WY
Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
[TBL] [Abstract][Full Text] [Related]
13. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
14. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
Matsui H; Kihara M; Usui H; Tate S; Mitsuhashi A; Shozu M
J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 2 Human Chorionic Gonadotropin Immunoassays Commercially Available for Monitoring Patients With Gestational Trophoblastic Disease.
de Souza JMQ; Braga A; Sanches Dos Santos R; Ramos MM; Cortés-Charry R; Maestá I
Int J Gynecol Cancer; 2017 Sep; 27(7):1494-1500. PubMed ID: 28692637
[TBL] [Abstract][Full Text] [Related]
18. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin.
Shapiro AI; Wu TF; Ballon SC; Lamb EJ
Obstet Gynecol; 1985 Apr; 65(4):545-9. PubMed ID: 2580254
[TBL] [Abstract][Full Text] [Related]
19. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
20. HCG--choosing the best assay to monitor gestational trophoblastic disease and other germ cell tumours.
Evans BD; Harvey VJ; Knox BS; Duff G
N Z Med J; 1993 Jun; 106(958):261. PubMed ID: 8392672
[No Abstract] [Full Text] [Related]
[Next] [New Search]